Semler Scientific (OTCMKTS:SMLR) released its quarterly earnings results on Sunday. The medical equipment provider reported $0.60 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.49 by $0.11, MarketWatch Earnings reports. Semler Scientific had a net margin of 32.08% and a return on equity of 67.38%.
SMLR traded down $1.25 during mid-day trading on Tuesday, hitting $112.00. The stock had a trading volume of 15,503 shares, compared to its average volume of 18,074. The stock’s fifty day simple moving average is $109.23 and its 200-day simple moving average is $91.17. The firm has a market capitalization of $752.30 million, a price-to-earnings ratio of 78.87, a price-to-earnings-growth ratio of 1.48 and a beta of 1.11. Semler Scientific has a 1-year low of $39.22 and a 1-year high of $118.97.
In related news, CEO Douglas Murphy-Chutorian sold 1,250 shares of the firm’s stock in a transaction on Monday, April 12th. The shares were sold at an average price of $108.21, for a total transaction of $135,262.50. Over the last 90 days, insiders have sold 3,750 shares of company stock worth $411,363. 13.60% of the stock is currently owned by company insiders.
About Semler Scientific
Semler Scientific, Inc develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Read More: What is a SEC Filing?
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.